12:03 25/09/2016 Brokerages Set Arena Pharmaceuticals Inc. (NASDAQ:ARNA) PT at $3.83
Brokerages Set Arena Pharmaceuticals Inc. (NASDAQ:ARNA) PT at $3.83
BBNS - 7 hours ago
Arena Pharmaceuticals logo Shares of Arena Pharmaceuticals Inc. (NASDAQ:ARNA) have earned a consensus recommendation of “Hold” from the nine ratings firms that are covering the stock.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Broker Price Targets For The Coming Week - Fiscal Standard

22:30 23/09/2016 Arena Pharmaceuticals Inc. (ARNA) is Trading Lower on Unusual Volume for ...
Arena Pharmaceuticals Inc. (ARNA) is Trading Lower on Unusual Volume for ...
Equities.com - Sep 23, 2016
Arena Pharmaceuticals Inc. (ARNA) experienced unusually high volume on Sep. 22, as the stock lost 0.56% to a closing price of $1.77.

16:00 22/09/2016 Price Target Analysis: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Price Target Analysis: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
News Oracle - Sep 22, 2016
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported its last earnings on Aug 08 AMC (BMO = before market open, AMC= after market close).
Analyst Research and Ratings: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ... - TWN
Notable Analysts Assessment of Stocks: Arena Pharmaceuticals, Inc. (NASDAQ ... - Street Updates

14:07 22/09/2016 Trading the Biotech News: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Dynavax ...
Trading the Biotech News: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Dynavax ...
The Voice Registrar - Sep 22, 2016
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) added 4.09% by the close of business day at $1.78. For the current quarter, the 7 Wall Street analysts issuing adjusted earnings per share outlook have a consensus estimate of -$0.07/share, which would ...

16:22 21/09/2016 The Insider Activity Don't Lie: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
The Insider Activity Don't Lie: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Review Fortune - Sep 21, 2016
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) up 14% for the past 5 days, is under coverage of 7 analysts who collectively assign a hold rating on stock.
Brokers Issue Forecasts for Arena Pharmaceuticals Inc.'s Q3 2016 Earnings (ARNA) - The Cerbat Gem
Analyst's PT Viewpoints: Medtronic plc (NYSE:MDT) , Arena Pharmaceuticals, Inc ... - Is stories

20:52 19/09/2016 Arena Launches Drug Discovery Incubator (ARNA)
Arena Launches Drug Discovery Incubator (ARNA)
Investopedia - Sep 19, 2016
In a well-planned move earlier this month, Arena Pharmaceuticals Inc. (ARNA) formed an independent, privately-held drug discovery incubator enterprise named Beacon Discovery Inc. (Beacon).

20:07 19/09/2016 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Insider Activities Are in the Air
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Insider Activities Are in the Air
Review Fortune - Sep 19, 2016
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) up 12.16% for the past 5 days, is under coverage of 0 analysts who collectively assign a hold rating on stock.
Research Analysts Issue Forecasts for Arena Pharmaceuticals Inc.'s Q3 2016 ... - Community Financial News
Arena Pharmaceuticals, Inc.'s (ARNA): Market Mover - Hot Stocks Point

14:25 16/09/2016 Time To Put On The Watch List? - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Time To Put On The Watch List? - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
The Voice Registrar - Sep 16, 2016
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) share price rose to $1.74 each in the last trading day compared to a prev close of $1.54.

13:12 16/09/2016 What are analysts Suggestions on: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
What are analysts Suggestions on: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
News Oracle - Sep 16, 2016
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported its last earnings on Aug 08 AMC (BMO = before market open, AMC= after market close).
Arena Pharmaceuticals, Inc. 277.4% Potential Upside Now Implied by FBR & Co. - DirectorsTalk Interviews

21:26 01/09/2016 Arena Pharmaceutics Announces Formation of Beacon Discovery
Arena Pharmaceutics Announces Formation of Beacon Discovery
PR Newswire (press release) - Sep 1, 2016
SAN DIEGO, Sept. 1, 2016 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced the formation of Beacon Discovery Inc. ("Beacon"), an independent, privately-held drug discovery incubator.